Can Nvidia Hit $300 by 2027? Here's Why the Answer Is Yes

NVIDIA was given a $229.78 12-month price target, implying 15.77% upside from $198.48, with a buy rating and 90% confidence. The article highlights strong fundamentals: Q4 FY2026 revenue of $68.13B, up 73.2% YoY, non-GAAP EPS of $1.62 beating consensus by 6.58%, and Q1 FY2027 guidance of $78.0B. Bulls see a path to $300 by end-2027 on Blackwell Ultra, Vera Rubin, and agentic AI demand, though China export controls remain a material risk.

Analysis

The market is still underestimating how much of NVIDIA’s next leg is a supply-chain monetization story rather than a pure multiple rerate. If hyperscalers keep converting capex into deployed AI clusters faster than software demand can absorb them, the bottleneck shifts from chips to power, networking, and rack integration — which means the next winners are likely to be the infrastructure enablers with the cleanest exposure to AI buildout, not the application layer. TSM should remain structurally supported as long as advanced-node demand and advanced packaging stay tight, while CRWV benefits from being a throughput conduit for deployed capacity even if its economics are lower quality than NVDA’s.

The real second-order risk is that the market is anchoring on unit demand while ignoring architecture migration risk. If inference economics improve faster than expected, customers may slow brute-force GPU purchases and reallocate toward custom silicon or mixed fleets, which compresses NVIDIA’s attach-rate and elongates upgrade cycles. That risk is not a near-term earnings issue; it is a 6-18 month valuation issue, because the stock is priced for continued dominance well into the Rubin transition.

China remains the cleanest downside catalyst, but the more actionable watch item is capex tone from Meta and OpenAI-like buyers over the next two reporting cycles. A modest softening in hyperscaler commentary would likely hit NVDA first and then propagate to TSM and CRWV through order timing, while META would be relatively resilient given its own compute intensity and internal demand. The contrarian view is that the consensus is too focused on whether NVDA can reach $300 and not enough on whether the broader AI supply chain is already priced for a too-smooth rollout; in that scenario, the best risk-adjusted trade is long the picks-and-shovels with a tighter stop on NVDA upside beta.

Key Decisions for Investors

• Maintain a core long NVDA but finance it by selling upside: buy NVDA shares or call spreads and overwrite with near-dated out-of-the-money calls into the next earnings cycle; this preserves upside to the mid-$220s while reducing exposure if the market starts discounting a slower Rubin ramp.
• Pair long TSM / short a basket of custom-silicon proxies over 3-6 months; if AI capex stays strong, TSM benefits from flow-through and packaging scarcity, while any acceleration in ASIC adoption should compress the most crowded alternative-exposure names first.
• Long CRWV on pullbacks only, with a strict position-size cap; the trade works if deployment velocity stays high, but the risk/reward degrades quickly if hyperscaler commentary turns cautious, so treat it as a tactical beta expression rather than a core fundamental long.
• Use META as a relative winner vs. NVDA over the next 1-2 quarters via a ratio long META / short NVDA when NVDA approaches sentiment-driven highs; META retains AI optionality while being less exposed to a single-product cycle reset.
• Set a 30-60 day catalyst watch on hyperscaler capex commentary and export-control headlines; if either turns negative, de-risk NVDA immediately and rotate into TSM or cash, since the first-order drawdown usually shows up in semiconductor multiples before fundamentals visibly roll over.